Plain-English translation of NCT04666454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Broken heart syndrome is a real medical condition where the heart temporarily weakens, usually after extreme stress or emotion. Right now, doctors don't have clear guidelines on the best medications to treat it. This trial is testing two different medication approaches—one using and dipyridamole, and another using apixaban—to see which helps patients recover best.
Doctors currently don't have strong evidence about which medications work best for broken heart syndrome. This trial aims to find the safest and most effective treatment so future patients get the best care right away.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to receive either the new medication approach or standard care. You'll take your assigned medication for about a month or until your heart function improves—whichever comes first. During this time, you'll have heart ultrasounds (echocardiograms) to monitor your recovery, typically at 2–4 days and again as needed. The trial involves about 1,000 patients across multiple hospitals in Europe.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Denmark
Norway
Sweden